DKDavid Kuter

David Kuter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Kuter has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discovery of a Novel DCAF1 Ligand Using a Drug–Target Interaction Prediction Model: Generalizing Machine Learning to New Drug Targets

    by Serah W. Kimani, Julie Owen, Stuart R. Green, Fengling Li, Yanjun Li, Aiping Dong, Peter J. Brown, Suzanne Ackloo, David Kuter, Cindy Yang, et al.

    DCAF1 functions as a substrate recruitment subunit for the RING-type CRL4DCAF1 and the HECT family EDVPDCAF1 E3 ubiquitin ligases. The WDR domain of DCAF1 serves as a binding platform for substrate proteins and is also targeted by HIV and SIV lentiviral adaptors to induce the ubiquitination and proteasomal degradation of antiviral host factors. It is therefore attractive both as a potential therapeutic target for the development of chemical inhibitors and as an E3 ligase that could be recruited by novel PROTACs for targeted protein degradation. In this study, we used a proteome-scale drug-target interaction prediction model, MatchMaker, combined with cheminformatics filtering and docking to identify ligands for the DCAF1 WDR domain. Biophysical screening and X-ray crystallographic studies of the predicted binders confirmed a selective ligand occupying the central cavity of the WDR domain. This study shows that artificial intelligence-enabled virtual screening methods can successfully be applied in the absence of previously known ligands.


  • Open Access

    Facile synthesis of a C4-symmetrical inherently chiral calix[4]arene

    by Luke Hodson, Kevin J. Visagie, Michael-Phillip Smith, Leigh Loots, David Kuter, Trégen M. Snayer, Gareth E. Arnott

    We report the facile synthesis of a rare C4-symmetric racemic inherently chiral calix[4]arene in one-step via tetracarbamate directing groups, and its resolution via diastereomer formation.


  • Open Access

    Accumulation of persistent tungsten in bone as in situ generated polytungstate

    by Cassidy R. VanderSchee, David Kuter, Alicia M. Bolt, Feng-Chun Lo, Renfei Feng, Juergen Thieme, Yu-Chen Karen Chen-Wiegart, Garth Williams, Koren K. Mann, D. Scott Bohle

    Tungsten accumulates in bone but is neither labile nor inert once absorbed. Tungsten’s relatively high cytosolic solubility and availability are problematic given its association with childhood lymphocytic leukemia. In light of tungsten’s technological prevalence, and the increased concern of regulatory agencies, here we characterize the chemical form and localization in mice exposed to tungsten through drinking water. Using X-ray fluorescence spectroscopy, we report accumulation of tungsten in bone tissue with some sites having ~10-fold greater intensities than background levels. The long bone tissue studied includes cortical, cancellous and bone marrow. Persistence of tungsten in cortical bone tissue following removal of the source indicates that it is retained in an insoluble form. The X-ray absorption near-edge structure spectra for tungsten in these tissues indicate that it is no longer in the originally administered form, orthotungstate, but rather resembles the heteropolytungsate species, phosphotungstate.


  • The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization

    by Sharné-Maré Fitzroy, Johandie Gildenhuys, Tania Olivier, Ndivhuwo Olga Tshililo, David Kuter, Katherine Allison de Villiers

    The throughput of a biomimetic lipid-mediated assay used to investigate the effects of inhibitors on the kinetics of β-hematin formation has been optimized through the use of 24-well microplates. The rate constant for β-hematin formation mediated by monopalmitoyl-rac-glycerol was reduced from 0.17 ± 0.04 min–1 previously measured in Falcon tubes to 0.019 ± 0.002 min–1 in the optimized assay. While this necessitated longer incubation times, transferring aliquots from multiple 24-well plates to a single 96-well plate for final absorbance measurements actually improved the overall turnaround time per inhibitor. This assay has been applied to investigate the effects of four clinically relevant antimalarial drugs (chloroquine, amodiaquine, quinidine, and quinine) as well as several short-chain 4-aminoquinoline derivatives and non-quinoline (benzamide) compounds on the kinetics of β-hematin formation. The adsorption strength of these inhibitors to crystalline β-hematin (Kads) was quantified using a theoretical kinetic model that is based on the Avrami equation and the Langmuir isotherm. Statistically significant linear correlations between lipid-mediated β-hematin inhibitory activity and Kads values for quinoline (r2 = 0.76, P-value = 0.0046) and non-quinoline compounds (r2 = 0.99, P-stat = 0.0006), as well as between parasite inhibitory activity (D10) and Kads values for quinoline antimalarial drugs and short-chain chloroquine derivatives (r2 = 0.64, P-value = 0.0098), provide a strong indication that drug action involves adsorption to the surface of β-hematin crystals. Independent support in this regard is provided by experiments that spectrophotometrically monitor the direct adsorption of antimalarial drugs to preformed β-hematin.


  • Open Access

    Insights into the initial stages of lipid-mediated haemozoin nucleation

    by David Kuter, Roxanne Mohunlal, Sharné-Maré Fitzroy, Constance Asher, Peter J. Smith, Timothy J. Egan, Katherine A. de Villiers

    Lipid-mediated haemozoin (Hz) formation was investigated using experimental and computational techniques. Glycerolipids (predominantly diacylglycerols), not phospholipids, were found entrapped by Hz crystals isolated from Plasmodium falciparum and consequently are proposed to nucleate Hz crystals in vivo. The initial stages of Hz formation were investigated using molecular dynamics simulations which involved modelling ferrihaem species pertinent to Hz formation (π–π and μ-propionato dimers) at lipid–water interfaces comprising a representative glycerolipid 1,2-dioleoyl-sn-glycerol (DOG) or phospholipid 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC). Simulations showed that π–π dimers partition into both lipids and remain near the hydrated lipid–water interface. Dimer aggregation, which was only observed in DOG, is proposed to be crucial for nucleating Hz. Indeed, β-haematin (synthetic Hz) production was found experimentally to be greater in DOG than DOPC (65 vs. 24%). Density functional theory calculations indicate that iron coordination by the carboxylate group of the propionate side chain, not the propionic acid group, is feasible in the aggregate. This can only occur, however, if ferrihaem is in a zwitterionic form with an axial water ligand, one propionic acid and one propionate side chain. UV-visible spectroscopy indicates that the presence of solvent water molecules is crucial for maintaining this species over a tautomeric form consisting of two propionic acid groups and an axial hydroxide ligand. Anhydrous conditions promote the latter tautomer which is unlikely to form Hz. A mechanism describing the initial stages of Hz formation is proposed based on these findings, which supports proposals that Hz crystal growth occurs in the lipid sub-phase.


  • Open Access

    Solid-state isolation of a unique, small-molecule, supra-heterodimer of large hexameric assemblies of C-methylcalix[4]resorcinarene

    by Clive L. Oliver, Nikoletta B. Báthori, Graham E. Jackson, David Kuter, Dyanne L. Cruickshank

    The well-known host molecule C-methylcalix[4]resorcinarene is shown to exist in two unique hexameric arrangements within the same crystal. These two hexameric assemblies are linked via a water molecule into a supra-heterodimer.


  • Solution structures of chloroquine–ferriheme complexes modeled using MD simulation and investigated by EXAFS spectroscopy

    by David Kuter, Victor Streltsov, Natalia Davydova, Gerhard A. Venter, Kevin J. Naidoo, Timothy J. Egan


  • Open Access

    Alkoxide coordination of iron(iii) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution

    by Johandie Gildenhuys, Chandre J. Sammy, Ronel Müller, Victor A. Streltsov, Tanya le Roex, David Kuter, Katherine A. de Villiers

    The quinoline methanol antimalarial drug mefloquine is a structural analogue of the Cinchona alkaloids, quinine and quinidine. We have elucidated the single crystal X-ray diffraction structure of the complexes formed between racemic erythro mefloquine and ferriprotoporphyrin IX (Fe(III)PPIX) and show that alkoxide coordination is a key interaction in the solid-state. Mass spectrometry confirms the existence of coordination complexes of quinine, quinidine and mefloquine to Fe(III)PPIX in acetonitrile. The length of the iron(III)–O bond in the quinine and quinidine complexes as determined by Extended X-ray Absorption Fine Structure (EXAFS) spectroscopy unequivocally confirms that coordination of the quinoline methanol compounds to Fe(III)PPIX occurs in non-aqueous aprotic solution via their benzylic alkoxide functional group. UV-visible spectrophotometric titrations of the low-spin bis-pyridyl-Fe(III)PPIX complex with each of the quinoline methanol compounds results in the displacement of a single pyridine molecule and subsequent formation of a six-coordinate pyridine–Fe(III)PPIX-drug complex. We propose that formation of the drug–Fe(III)PPIX coordination complexes is favoured in a non-aqueous environment, such as that found in lipid bodies or membranes in the malaria parasite, and that their existence may contribute to the mechanism of haemozoin inhibition or other toxicity effects that lead ultimately to parasite death. In either case, coordination is a key interaction to be considered in the design of novel antimalarial drug candidates.


  • Molecular Structures and Solvation of Free Monomeric and Dimeric Ferriheme in Aqueous Solution: Insights from Molecular Dynamics Simulations and Extended X-ray Absorption Fine Structure Spectroscopy

    by David Kuter, Victor Streltsov, Natalia Davydova, Gerhard A. Venter, Kevin J. Naidoo, Timothy J. Egan

    CHARMM force field parameters have been developed to model nonprotein bound five-coordinate ferriheme (ferriprotoporphyrin IX) species in aqueous solution. Structures and solvation were determined from molecular dynamics (MD) simulations at 298 K of monomeric [HO-ferriheme]2–, [H2O-ferriheme]−, and [H2O-ferriheme]0; π–π dimeric [(HO-ferriheme)2]4–, [(H2O-ferriheme)(HO-ferriheme)]3–, [(H2O-ferriheme)2]2–, and [(H2O-ferriheme)2]0; and μ-oxo dimeric [μ-(ferriheme)2O]4–. Solvation of monomeric species predominated around the axial ligand, meso-hydrogen atoms of the porphyrin ring (Hmeso), and the unligated face. Existence of π–π ferriheme dimers in aqueous solution was supported by MD calculations where such dimers remained associated over the course of the simulation. Porphyrin rings were essentially coplanar. In these dimers major and minor solvation was observed around the axial ligand and Hmeso positions, respectively. In μ-oxo ferriheme, strong solvation of the unligated face and bridging oxide ligand was observed. The solution structure of the μ-oxo dimer was investigated using extended X-ray absorption fine structure (EXAFS) spectroscopy. The EXAFS spectrum obtained from frozen solution was markedly different from that recorded on dried μ-oxo ferriheme solid. Inclusion of five solvent molecules obtained from spatial distribution functions in the structure generated from MD simulation was required to produce acceptable fits to the EXAFS spectra of the dimer in solution, while the solid was suitably fitted using the crystal structure of μ-oxo ferriheme dimethyl ester which included no solvent molecules.